ArticleRadiation oncology (London, England)2018

ATR kinase inhibitors NVP-BEZ235 and AZD6738 effectively penetrate the brain after systemic administration.

Guido Fròsina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.